Increased mortality associated with growth hormone treatment in critically ill adults.
暂无分享,去创建一个
[1] P. Cole,et al. Growth hormone is a human macrophage activating factor. Priming of human monocytes for enhanced release of H2O2. , 1995, Journal of immunology.
[2] D. Wilmore,et al. Growth Hormone Stimulates Protein Synthesis during Hypocaloric Parenteral Nutrition: Role of Hormonal‐Substrate Environment , 1988, Annals of surgery.
[3] M. Rennie,et al. Muscle protein turnover and the wasting due to injury and disease. , 1985, British medical bulletin.
[4] J. L. Gall,et al. APACHE II--a severity of disease classification system. , 1986, Critical care medicine.
[5] D. Wilmore,et al. Use of growth hormone for postoperative respiratory failure. , 1996, American journal of surgery.
[6] G. Van den Berghe,et al. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. , 1997, The Journal of clinical endocrinology and metabolism.
[7] J. H. Shaw,et al. Anabolic and cardiovascular effects of recombinant human growth hormone in surgical patients with sepsis , 1996, The British journal of surgery.
[8] D. Löhlein,et al. Improved cumulated nitrogen balance after administration of recombinant human growth hormone in patients undergoing gastrointestinal surgery. , 1994, Infusionstherapie und Transfusionsmedizin.
[9] B. Angelin,et al. Growth hormone potentiates the in vivo biological activities of endotoxin in the rat , 1996, European journal of clinical investigation.
[10] D. Wilmore,et al. Low‐Dose Growth Hormone and Hypocaloric Nutrition Attenuate the Protein‐Catabolic Response After Major Operation , 1989, Annals of surgery.
[11] K. Noonan,et al. The effect of growth hormone replacement therapy on cortisol–cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11β‐hydroxysteroid dehydrogenase activity , 1998, Clinical endocrinology.
[12] S. Lowry,et al. Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: a double-blind, randomized controlled study. , 1992, The Journal of clinical endocrinology and metabolism.
[13] A. Benzer,et al. Improvement of septic syndrome after administration of recombinant human growth hormone (rhGH)? , 1991, The Journal of trauma.
[14] R. S. V. STRACK VAN SCHIJNDEL,et al. Effects of Recombinant Human Growth Hormone in Patients With Severe Sepsis , 1992, Annals of surgery.
[15] R. Dantzer,et al. Hypophysectomy Inhibits the Synthesis of Tumor Necrosis Factor α by Rat Macrophages: Partial Restoration by Exogenous Growth Hormone or Interferon γ , 1991 .
[16] J. Mälstam,et al. Therapeutic intervention scoring system (TISS) — a method for measuring workload and calculating costs in the ICU , 1992, Acta anaesthesiologica Scandinavica.
[17] D. Clemmons,et al. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. , 1991, Chest.
[18] M. Jeevanandam,et al. Altered lipid kinetics in adjuvant recombinant human growth hormone-treated multiple-trauma patients. , 1994, The American journal of physiology.
[19] J. Wernerman,et al. Biosynthetic Human Growth Hormone Preserves Both Muscle Protein Synthesis and the Decrease in Muscle‐free Glutamine, and Improves Whole‐body Nitrogen Economy After Operation , 1992, Annals of surgery.
[20] J. Nauta,et al. Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial. , 1995, Critical care medicine.
[21] T. Elsasser,et al. Recombinant bovine somatotropin blunts plasma tumor necrosis factor-alpha, cortisol, and thromboxane-B2 responses to endotoxin in vivo. , 1994, Endocrinology.
[22] K. Fukatsu,et al. Growth hormone and insulinlike growth factor I enhance host defense in a murine sepsis model. , 1995, Archives of surgery.
[23] D. Wilmore,et al. Increased survival after major thermal injury: the effect of growth hormone therapy in adults. , 1995, The Journal of trauma.
[24] C. Pichard,et al. Lack of effects of recombinant growth hormone on muscle function in patients requiring prolonged mechanical ventilation: a prospective, randomized, controlled study. , 1996, Critical care medicine.
[25] D. Halliday,et al. POSTOPERATIVE POSITIVE NITROGEN BALANCE WITH INTRAVENOUS HYPONUTRITION AND GROWTH HORMONE , 1988, The Lancet.
[26] M. Jeevanandam,et al. Adjuvant recombinant human growth hormone normalizes plasma amino acids in parenterally fed trauma patients. , 1995, JPEN. Journal of parenteral and enteral nutrition.
[27] L. Broemeling,et al. Effects of recombinant human growth hormone on donor-site healing in severely burned children. , 1990, Annals of surgery.
[28] G. Biolo,et al. Effects of growth hormone administration on skeletal muscle glutamine metabolism in severely traumatized patients: preliminary report. , 1997, Clinical nutrition.
[29] T Bendix,et al. Fatigue and cardiorespiratory function following abdominal surgery , 1982, The British journal of surgery.
[30] I. Macdonald,et al. Increased whole body protein breakdown predominates over increased whole body protein synthesis in multiple organ failure. , 1993, Clinical science.
[31] R. Wolfe,et al. Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. , 1991, Archives of surgery.
[32] B. Pedersen,et al. In vitro effects of human growth hormone on the proliferative responses and cytokine production of blood mononuclear cells. , 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[33] A Kari,et al. Septic shock and multiple organ failure , 1991, Critical care medicine.
[34] J. Holly,et al. Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease. , 1996, Critical care medicine.
[35] D. Wilmore,et al. Growth hormone attenuates the abnormal distribution of body water in critically ill surgical patients. , 1992, Surgery.
[36] J. Miell,et al. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin–like growth factor‐I , 1991, Clinical endocrinology.
[37] J. Nauta,et al. Effects of human growth hormone on fuel utilization and mineral balance in critically ill patients on full intravenous nutritional support. , 1994, Journal of critical care.
[38] V. Kvetan,et al. Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition. , 1990, Archives of internal medicine.